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the role of naV channels in synaptic 
transmission after axotomy in a 
microfluidic culture platform
nickolai Vysokov, Stephen B. McMahon  & Ramin Raouf  
Voltage gated sodium channels are key players in aberrant pain signaling and sensitization of 
nociceptors after peripheral nerve injury. The extent to which sodium channel activity after injury 
contributes to synaptic transmission at the first pain synapse however remains unclear. To investigate 
the effect of axotomy on synaptic transmission between dorsal root ganglia neurons and dorsal horn 
neurons, we reconstructed the first pain synapse in a novel microfluidic based compartmentalized 
cell culture system, which recapitulates the connectivity of peripheral pain signaling. We show 
that following axotomy of the distal axons, inhibition of NaV1.7 and NaV1.8 sodium channels in 
incoming presynaptic DRG axons is no longer sufficient to block activation of these axons and the 
resulting synaptic transmission to dorsal horn neurons. We found that blockade of NaV1.6 activity is 
highly effective in reducing activation of incoming axons contributing to synaptic transmission after 
axotomy of DRG neurons. The microfluidic culture system described here offers an in vitro platform to 
recapitulate and study the first pain synapse.
Perception of pain relies on transduction of nociceptive stimuli in the peripheral endings of dorsal root ganglion 
(DRG) neurons and transmission of these action potentials to dorsal horn (DH) neurons of the spinal cord in 
the central nervous system. Voltage gated sodium channels (NaVs) are critical for generation and propagation 
of action potential in sensory neurons1. NaV1.7, NaV1.8, and NaV1.9 are predominantly expressed in DRG neu-
rons and have been the focus of drug discovery efforts due to their role nociception2,3 and neuropathic pain 
conditions4–7.
Mice lacking NaV1.8 and NaV1.7 channels exhibit deficits in nociception, as well as in inflammatory and neu-
ropathic pain models8,9. Loss-of-function mutations of NaV1.7 are known to result in complete insensitivity to 
pain in humans10–13 and gain of function mutations in NaV1.8 and NaV1.7 channels may contribute to painful 
peripheral neuropathies14,15. However, drugs that effectively block these channels have so far proven ineffective in 
clinical trials on neuropathic pain16.
Although the contribution of NaV1.8 and NaV1.7 channels to excitability of sensory neurons is well estab-
lished, their role in synaptic transmission remains unclear. Modulation of pain at the first pain synapse is an effec-
tive route to pain relief. Drugs such as gabapentin and opioids, which attenuate neurotransmission between DRG 
and DH neurons, are highly effective in the clinic17,18. Their side effects, desensitization and addictive nature, 
however, call for development of other strategies for blocking the synaptic transmission.
Studies on the synapses between nociceptive DRG neurons innervating DH neurons in the spinal cord, i.e. 
the first pain synapse, have been hampered by lack in vitro of model systems to capture the physiology of the sys-
tem19. Current cell culture models allow tight control of the microenvironment of the synapses, and can be used 
to investigate how synapse formation is modulated through interactions with other neurons or non-neuronal 
cells19. However, neither localized pharmacological interventions nor axonal injury are possible with these cul-
tures. Using a microfluidic compartmentalization technology where microfluidic channels with a very small 
cross-section were used to separate cell bodies from axons, was pivotal for allowing short-term and long-term 
manipulations of axons separately from cell bodies20–22. This concept was also successfully used to show that 
damaging DRG axons by axotomy can make them chronically more sensitive to depolarizing stimuli23. Thus, the 
ability to independently control the axonal microenvironment, apply and wash off defined concentrations of any 
soluble compound, and to perform distal axotomy of DRG neurons, make this microfluidic compartmentalization 
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a uniquely versatile and robust tool for studying molecular mechanisms involved in modulation of the synaptic 
function in response to axonal damage.
In order to investigate the role of NaVs in synaptic transmission, we developed a culture model using DRG 
and DH neurons in a three-compartment microfluidic platform. We characterized the platform to verify the 
identity of the DRG neurons, their ability to send axons bilaterally and to convey a stimulus from far compart-
ment (Periphery) to the DH neurons in the near compartment (DH compartment). We show that the DRG 
neurons form functional synapses with the DH neurons, recapitulating the two components of the peripheral 
pain pathway. We found that while blocking pre-synaptic NaV1.7 and NaV1.8 channels is effective in reducing 
synaptic transmission in un-injured cultures, the same blockers are ineffective in cultures where the DRG axons 
in the Periphery compartment had been axotomized. We have investigated further the expression of other NaVs to 
explain the lack of efficacy of NaV1.7 and NaV1.8 blockers in injured DRG neurons. We propose that the changes 
in pre-synaptic activity and pharmacological profile observed in this microfluidic model of first pain syanpase, 
should be considered when studying mechnisms of neuropathic pain.
Results
Reconstituting the peripheral nociceptive pathway using microfluidic co-cultures of DRG and 
DH neurons. In order to investigate synaptic transmission between DRG and DH neurons after axonal injury, 
we established a compartmentalized co-culture model to re-capitulate the relevant aspects of peripheral nocic-
eptive circuitry in a dish. Rat embryonic DRG and DH neurons were dissociated and cultured in separate com-
partments of a three-compartment microfluidic device. One compartment contained no cells (only DRG axons), 
dissociated DRG neurons were cultured in the middle compartment and DH neurons were grown in the third 
(Fig. 1). So, we refer to these compartments as Periphery, DRG and DH respectively.
The cultures were maintained for 12–16 days by which time many of the markers for mature DRG neu-
rons, such as expression of TRPV1 (Figure S1), NaV1.8 (Figure S2), the ability to bind IB4 (Figure S1b), and 
Figure 1. Schematic of the microfluidic co-culture setup. Embryonic (E16) rat dorsal root ganglia (DRG) and 
spinal cord dorsal horns (DH) were extracted, digested, dissociated and plated into different compartments of a 
microfluidic device in serum-free medium with NGF and AraC and allowed to mature for 12–16 DIV.
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the ability of a subset of DRG neurons to respond to capsaicin stimulation (Figure S1a). DRG axons traversed 
micro-channels from DRG compartment to both Periphery and the DH compartments (Figures S2 and S3). We 
traced DRG neurons with axons traversing into both fluidically isolated Periphery and DH compartments using 
tracer DiI and DiO. In this manner we labeled DRG soma that had axons leading into the Periphery compartment 
with DiO and into the DH compartment with DiI and found that 36 ± 14% of DRG neurons had crossed bilater-
ally into the Periphery and DH compartments (Fig. 2a).
The DRG axons in both compartments were able to conduct action potentials and activation of the DRG 
axons by a depolarizing stimulus (30 mM KCl) from either Periphery or DH compartments could elicit calcium 
transients in DRG soma compartment (Fig. 2b). We found that on average 18 ± 7% of DRG soma responding to 
stimulation in either Periphery or DH compartments have also responded to stimulation in the other compart-
ment (Fig. 2b) indicating bilateral crossing of electrically competent axons from these DRG neurons. We further 
examined the response properties of these axons and found that past 12 DIV, a subset of these axons responded 
robustly to stimulation with capsaicin (Figure S4a). Hence, the DRG axons in microfluidic cultures recapitulated 
the bilateral innervation of the peripheral targets and the DH neurons of the spinal cord.
We then investigated if the DRG axons traversing to DH compartment made synaptic contacts with the DH 
neurons. We used electrical (10 impulses @ 5 Hz, see schematic in Fig. 3a) or chemical (30 mM KCl, Figure S4b) 
stimulation applied to Periphery and found that this elicited a robust transient calcium response in a subpop-
ulation of DH neurons (Fig. 3a,c, “baseline response” and Figure S4b, top left panel) in all co-cultures tested. 
Electrical stimulation of the DRG axons in the Periphery also elicited excitatory post-synaptic currents in the 
DH neurons (EPSCs, Fig. 3c). We then used 5 mM lidocaine for blocking action potential propagation in the 
DRG compartment to further confirm that the responses elicited in DH neurons were due to propagation of the 
action potential generated in the DRG axons. We found that lidocaine completely eliminates any response of the 
DH neurons to the electrical stimulus (Fig. 3a,b). However, the microflouidic isolation confines lidocaine to the 
DRG compartment and the dorsal horn as DH neurons retained spontaneous network activity in the presence 
of lidocaine (Fig. 3b, top panels). The response of the DH neurons relies on glutamatergic synaptic transmission, 
as treatment with MK-801 and CNQX blockers of NMDA and AMPA receptors, respectively, in the DH com-
partment, resulted in near complete elimination of the calcium responses and the EPSCs in the DH neurons 
(Fig. 3c,d). These data confirm that the microfluidic co-cultures of DRG and DH neurons recapitulate many 
features of the peripheral pain pathway.
The impact of axotomy on synaptic transmission to DH neurons. We set out to investigate the 
impact of axonal injury on NaV channel activity in presynaptic axons using the microfluidic co-culture model. 
The microfluidic isolation of DRG axons in the Periphery compartment enabled application of shear stress20 to 
this compartment for specific injury to only those axons, which had crossed from the DRG into the Periphery 
compartment. This model of axonal injury in vitro in which distal axons were axotomized (severed) and allowed 
to regrow, was previously used for studying changes in NaV channels in the injured axons23. We used the same 
protocol for axonal injury (see schematic in Fig. 4a). As predicted, axotomy led to increase in stress-related 
Figure 2. DRG neurons traverse bilaterally into Periphery and DH compartments in the microfluidic co-
cultures. (a) To examine axonal crossing, the tracer dyes DiO (green, added to the Periphery compartment) 
and DiI (red, added to DH compartment) are taken up by the DRG neurons and reveal cells with neurites in 
both compartments in yellow (yellow arrows point to examples) as in schematic and representative image. 
Quantification (n = 4 independent cultures) reveals that 36% ± 14% (SEM) of all labeled cells can take up both 
dyes indicating that they have crossed bilaterally. (b) The DRG neurons could be activated (detected by live 
ratiometric Ca2+ imaging, where the images have been processed to highlight changes in Ca2+ levels relative to 
baseline, see “Methods” for details) by mild depolarization with 30 mM KCl applied to Periphery (left panel) 
or DH (middle panel). After false-coloring and overlay, cells in yellow (yellow arrows) respond to both stimuli. 
Quantification reveals that 18% ± 7% (SEM, n = 6) of DRG neurons responding to either stimulus are able to 
respond to stimulation of their axons from Peripheral as well as DH compartments indicating bilateral crossing 
of axons able to conduct action potentials. Scale bars are 100 µm.
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marker ATF3. We found that the expression of ATF3 was significantly up-regulated in the DRG soma 3 days 
after axotomy in the Periphery compartment, indicating the impact of axotomy on the DRG neurons after 3 days 
(Figures S6 and S7). The calcium responses (ΔR/R0) in DH neurons to stimulation of axotomized DRG axons 
in the Periphery compartment were comparable to uninjured co-cultures (p = 0.28, n = 7 Fig. 4b–e). This data 
suggests that in our model where DRG axons were axotomized and allowed to recover for 3 days, there is no sig-
nificant decrease in the strength of synaptic connections between DRG and DH neurons after axotomy.
Changes in pre-synaptic NaV1.7 and NaV1.8 pharmacology following Peripheral axotomy. We 
then focused on the role of NaV1.8 and NaV1.7 in synaptic transmission to DH neurons following axonal injury. 
We confirmed by immunocytochemistry that both channel subunits were expressed in DRG axons in all three 
compartments (NaV1.8 was expressed only in a subset of axons) but not expressed in DH neurons (Figure S3a for 
NaV1.7 and Figure S2a for NaV1.8). We also confirmed that NaV1.7 and NaV1.8 blockers (100 nM ProTXII and 
1 µM A803467 respectively) are able to block a significant proportion of Na+ currents in our 12–16 DIV DRG 
neurons at the selected concentration (Figures S3b, c and S2b, c). We used a combination of NaV1.7 and NaV1.8 
blockers in the DH compartment to examine the response of DH neurons to electrical stimulation of DRG axons 
in Periphery (see schematic in Fig. 4a). In uninjured co-cultures the response of DH neurons in presence of these 
blockers was significantly reduced on average (Fig. 4d, p = 0.0044, n = 7) and almost completely eliminated in 
some cells as shown in representative images and traces (Fig. 4b, top panel and 4c). Washing the blockers par-
tially restored the response to the original signal amplitude (Fig. 4b–d, right panels and right bar). However, in 
Figure 3. Stimulation applied to the Periphery compartment is transmitted via DRG neurons to activate 
DH neurons. Response of DH neurons to electrical stimulation (10 biphasic pulses at 5 Hz × 2 ms@40 µA) of 
Periphery was measured by calcium imaging (a and c) or by whole-cell voltage clamp recording of dorsal horn 
neurons (b and d). The Ca2+ response (average ΔR/R, see calcium imaging analysis in methods) and EPSCs are 
observed in a subset of DH neurons during application of the electrical stimulus (“Baseline response”). (a and b) 
The response in DH neurones is completely abolished after blocking signal transduction by applying 5 mM 
lidocaine to DRGs. Note, that lidocaine added to DRG soma did not abolish the spontaneous network activity 
in the DH soma compartment (b, “Spontaneous EPSCs”). (c and d) Blocking glutamatergic trans-synaptic 
transmission of signal by application of AMPA and NMDA glutamate receptor blockers (20 µM CNQX, 1 µM 
MK-801) to DH compartment almost completely blocks the response of the dorsal horn neurons to stimulation 
of the Periphery (only stimulation artifacts colored in red remain). Washing these drugs partially restores the 
response (right panels). Scale bars are 100 µm.
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Figure 4. Blocking pre-synaptic NaV1.7 and NaV1.8 channels reduces response of DH neurons to stimulation 
of the Periphery compartment, but not in co-cultures where DRG axons had been injured. (a) Schematic of the 
experiment – DRG axons in the Periphery compartment were axotomized as described in methods and allowed 
to recover from acute effects of injury for 3 DIV. The response of DH neurons to electrical stimulation of 
Periphery with or without drugs in the DH compartment was recorded using Fura-2. (b and c) Representative 
images (b) and traces from representative DH neurons (c) showing responding DH neurons from control (top 
panel in (b), black trace in (c)) and axotomized (bottom panel in (b), red trace in (c)) co-cultures before drug 
application (left panels), and after application of 100 nM ProTXII (NaV1.7 blocker) and 1 µM A803467 (NaV1.8 
blocker) to the DH compartment (middle panels). Note that the drugs significantly reduce or even abolish 
the response of some of the DH neurons in control but are ineffective in axotomized cultures. The response is 
partially restored after wash (right panels). (d–f) Quantification and statistical analysis of the effects of drugs on 
response of DH neurons to the electrical stimulus in Periphery. Peak amplitude (ΔR/R) after application of the 
blockers to uninjured (d) and injured (e) cultures, 3 days post axotomy, did not reduce the response amplitude 
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axotomized cultures, application of the same inhibitors to block NaV1.7 and NaV1.8 in the DH compartment had 
no effect (Fig. 4b, bottom panel and 4c, red trace and 4d, p = 0.376, n = 6). By looking at the proportion of cells 
affected by NaV1.7 and NaV1.8 blockers we can directly observe the striking difference between the pharmacolog-
ical profile of injured and uninjured cultures (Fig. 4f, p = 0.017, n = 7). These data show that synaptic transmission 
at the DRG-DH synapse following axotomy of distal DRG axons, can take place independently of NaV1.7 and 
NaV1.8 channels, and the unexpected difference, suggests aberrant NaV channel activity in axotomized neurons.
naV 1.6 is the dominant sodium channel subunit following injury to distal axons. We hypoth-
esized that the observed lack of effect of NaV1.7 and NaV1.8 blockers in injured cultures could be due to changes 
in expression of one or more voltage-gated sodium channel subunits. The compartmentalization allowed for 
extraction of RNA material specifically from the DRG compartment to screen for changes at the mRNA level in 
the DRGs following axotomy (see Methods and Fig. 5a).
Since NaV1.4 and NaV1.5 are not expressed by DRG neurons (also confirmed by PCR, Figure S7A), we focused 
our analysis on NaV1.1–1.3 and 1.6–1.9. The most highly expressed VGSC was NaV1.7 (Scn9a, Figure S7A which 
is expressed by the majority of DRG neurons (also see immunocytochemistry in Figure S3A) and it was not 
significantly different from the control. While the expression of Scn10a, second highest expressed channel in 
our analysis), Scn11a, Scn2a, and Scn3a followed a trend of being up-regulated, they did not pass statistical sig-
nificance following adjustment for multiple comparisons (p < 0.10). It is possible that higher changes in levels of 
expression were masked by DRG cells that did not cross into the Periphery compartment (~60 ± 8% of all DRGs) 
and it was not possible to separate these out. However, interestingly, despite this disadvantage, the expression 
of NaV1.6 (Scn8a) was found to be significantly upregulated by 25% in DRG cells (Fig. 5b, p < 0.05, n = 7, t-test 
with Bonferroni post-hoc correction). We confirmed expression of NaV1.6 in DRG soma, axons in the Periphery 
and DH compartments by immunocytochemistry and we also found DH neurons to strongly express NaV1.6 
(Figure S5a). These data suggested that the upregulation of NaV1.6 in presynaptic axons following injury to distal 
axons could contribute to synaptic transmission to DH neurons.
Blocking naV1.6 is effective in reducing activation of DRG axons that “innervate” DH compart-
ment. We next hypothesized that the changes in NaV channels expression observed in the DRG neurons could 
underlie axotomy-induced changes in pharmacology of signal transmission to DH neurons. In order to inves-
tigate contribution of NaV channels to the propagation of action potential in DRG axons innervating the DH 
compartment, we took advantage of a replication-deficient adeno-associated virus with the gene to encode Ca2+ 
indicator GCaMP6s in host cells. When added to the Periphery it is taken up by crossing DRG axons and the 
GCaMP becomes expressed throughout the whole neuron. Thus, all GCaMP positive axons in the DH compart-
ment could only have come from bilaterally crossing DRG neurons transduced by the virus and, moreover, these 
would have also all been injured when axotomy was performed as the virus was added prior to the procedure 
(see schematic in Fig. 6a). In this way we were able to reliably identify and restrict analysis to axons from DRG 
neurons, which have undergone axotomy.
Electrical stimulation of DRG axons in the Periphery compartment elicited a Ca2+ transient response in the 
axons of bilaterally crossing DRGs in the DH compartment (Fig. 6b,c, left panels). These axons responded to 
application of KCl to the Periphery compartment. A subset of the axons responded to stimulation with capsaicin, 
suggesting that the major DRG neuronal subtypes have bilaterally crossing axons (Figure S4a). In this paradigm, 
addition of NaV1.7 and NaV1.8 blockers to the DH compartment resulted in significant reduction of the response 
in a subset of the DRG axons in the DH compartment (Fig. 6b,c). In axotomized cultures, however, the combina-
tion of ProTXII and A803467 had no significant effect on axonal responses (Fig. 6b,c), which is consistent with the 
effects observed postsynaptically on the responses of DH neurons following axotomy (Fig. 4b,c). Quantification 
of this pharmacological phenotype revealed a statistically significant difference between changes in number of 
responding axons after incubation with the two inhibitors in axotomized neurons (no effect: −1 ± 4%) and in 
control (reduction by 20 ± 8%; p = 0.039).
We then tested whether NaV1.6 could be mediating transmission of signals in DRG axons in the DH compart-
ment. We used a metabolite of TTX – 4,9-Anhydrotetrodotoxin (AHTTX), which specifically blocks NaV1.624. 
We found that 500 nM AHTTX partially blocks Na+ currents in DRG neurons (Figure S5a). We also found that 
the addition of AHTTX together with ProTXII and A803467 significantly reduced or completely abolished the 
response of a 52 ± 12% axons, which did not respond to addition ProTXII and A803467 alone in axotomized cul-
tures (p = 0.002, n = 9). The Ca2+ response in the DRG axons is partially or completely restored after washing the 
blockers, suggesting that the reduction observed is specifically due to the addition of the combination of blockers. 
These data confirmed a novel role for NaV1.6 subunit as the dominant sodium channel, in the excitability of DRG 
axons innervating DH neurons following axotomy at the distal axons in a microfluidic culture model.
Discussion
In this study we developed a novel microfluidic based culture model to investigate responses to axonal injury and 
found unexpected changes in NaV channel activity following injury. The in vitro model of compartmentalized 
DRG and DH neuron co-culture for studying signal transmission between the peripheral and central neurons 
of DH neurons in injured cultures. (*p < 0.05, **p < 0.01, Student’s t-test with Bonferroni post-hoc correction; 
n = 7 cultures) (f) The proportion of DH neurons that exhibited more than 50% reduction in peak amplitude 
(ΔR/R) after application of the blockers of ProTXII and A803467 to DH compartment was greatly reduced 
(*p = 0.017, Welch’s t-test, n = 7 cultures).
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developed for this paper recapitulates the bilateral nature of DRG neurons synapsing onto the dorsal horn cells 
in the DH compartment and extending their axons into the Periphery compartment at the same time (Figs 1–3). 
Moreover, it was combined with the previously published approach for inducing chronic sensitization by injury 
in DRG axons23. The present approach has numerous advantages over other in vitro and ex vivo models studying 
DRG-DH communication19,25,26 including specific and controlled manipulations of DRG axons in the Periphery 
(e.g. axotomy in Figs 4–6 and viral transduction in Fig. 6) or synapses and cells in the DH compartment (phar-
macology in Figs 3, 4, 6). Reconstruction of neuronal circuitry in microfluidic platform affords direct local appli-
cation of pharmacological modulators with concomitant measurements of neuronal activity using fluorometry 
or patch clamp electrorphysiology23. Performing in vivo patch clamp electrophysiology on the spinal cord dorsal 
horn neurons is technically limited and suffers low throughput data collection. Moreover, the microfluidic cul-
tures offer a platform whereby to study neuronal and synaptic responses to axonal manupilations, but also the 
interaction with other systems such the immune cells23,27,28.
In our model the cells were extracted from rat embryonic E16 neurons, which dramatically improves their 
long-term survival and makes the model more robust than short-term cultures from adult rat tissue. The expres-
sion of NaV1.7 and NaV1.8 channels is initially low29, however, over the culture period (12–16 DIV) and in the 
presence of NGF these cells mature, expanding in size, expressing markers for mature nociceptors with the 
smaller neurons binding IB4 (Figure S1b), expressing NaV1.7 and NaV1.8 subunits (Figures S3 and S4), and func-
tional TRPV1 receptors (Figures S1 and S2). Moreover, they made functional glutamatergic synapses with the DH 
neurons (Fig. 3c,d) and undergo molecular changes in response to axonal injury (a corollary of peripheral nerve 
injury) (Figs 4–6, Figure S6). However, a caveat for using primary embryonic neurons matured in culture is that 
the stage of maturation achieved in culture may not directly correspond to mature neurons in vivo. Extension of 
this platform to host more mature tissue, such as postnatal neurons, would be of interest in this regard.
We showed here that a microfluidic culture platform can be used to study the modulation of synaptic trans-
mission between DRG neurons and DH neurons. We used this platform to investigate the impact of axotomy 
on synaptic transmission between DRG and DH neurons. Neuropathic pain is highly prevalent in patients with 
peripheral nerve injuries that involve axotomy of a subset of the sensory neurons30 and many studies support 
the involvement of the axotomized subset of DRG neurons in the Spinal Nerve Ligation, Spared Nerve Injury 
and Chronic Constriction Injury models of neuropathic pain30–32. As such understanding the axotomy-induced 
changes in synaptic transmission is highly relevant to understanding pathological pain. Recapitulating other types 
of injury such as partial nerve damage, however, would be technically prohibitive in the microfluidic culture 
platform in its current form.
We further showed that this microfluidic platform can recapitulate the salient features of the periph-
eral pain pathway and hence, could be used for studying the pharmacology of the peripheral nerve injury. 
Furthermore, there is scope for modifying the device design for high-throughput applications in industrial 
screening against synaptic transmission at the first pain synapse. Thus, the microfluidic platform we describe 
here, is to our knowledge, the first to exploit the versatility of microfluidic devices to model injury induced func-
tional changes in neuronal circuits in vitro. One important disadvantage of the models is that it does not capture 
the entire complexity of in vivo pain signaling, and the findings should ultimately be validated using animal mod-
els. Despite this caveat, the microfluidic culture platform described here goes a long way towards a physiologically 
relevant surrogate cell culture model to study mechanisms of pathological pain. As a surrogate for in vivo pain 
models, application of this microfluidic based in vitro model of neuropathic pain in the study of pain transmission 
after peripheral nerve damage, can ultimately lead to a significant reduction in the number of animals needed for 
such projects.
Figure 5. Changes in NaV mRNA expression in axotomized DRG neurons. (a) Schematic of the experiment. 
3 DIV after axotomy the RNA from axotomized and control DRG neurons was collected, and differences 
in expression of VGSCs were analyzed by qPCR (see methods for details). (b) Quantification of changes in 
NaV mRNA expression (NaV1.4 and NaV1.5 were not expressed in both conditions) in axotomised cultures, 
compared to control. NaV1.6 (Scn8a) is significantly upregulated in DRG neurons following injury (*p < 0.05, 
One-sample t-test with Bonferroni post-hoc correction; n = 7; error bars represent SEM). See Figure S7 for 
relative expression levels of other genes.
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Figure 6. 4,9-AHTTX is effective at blocking Ca2+ responses in DRG axons, which are not blocked by 
ProTXII and A803467. (a) Schematic of the protocol. AAV particles encoding for GCaMP6s gene were added 
to Periphery compartment and taken up by DRGs with axons that have crossed by 6 DIV. At 12–13 DIV the 
axons were injured (as above). The effect of peripheral injury on the DRG axons in the DH compartment and 
their pharmacology was investigated by imaging GCaMP fluorescence response (ΔF) to electrical stimulation 
(10 pulses at 5 Hz × 2 ms@40 µA, biphasic). (b) DRG axons in DH compartment from control (top panel) or 
axotomized cells (bottom panel) express GCaMP and respond to electrical pulses applied to Periphery with 
transient increases in fluorescence (first column – “response before drug application”). Note how populations 
of axons disappear when treated with drugs (100 nM ProTXII, 1 µM A803467, 500 nM AHTTX), while other 
populations remain unaffected. (c) Traces showing transient Ca2+ spikes (expressed in arbitrary units from 
ΔF/F) in representative DRG axons from control (black) and axotomized (red) cultures following electrical 
stimulation (black bar) in presence of the same drug combinations. (d) Quantification of axons responding to 
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Our aim here was to illustrate the utility of the microfluidic model in investigating modulation of synaptic 
transmission between DRG and DH neurons in the DH compartment. We had reported previously that axoto-
mizing DRG neurons in microfluidic devices lead to robust changes in DRG axons excitability at the site of 
damage in the periphery compartment23. Using our microfluidic model of peripheral pain pathway, we examined 
the role of NaV1.7 and NaV1.8 in trans-synaptic transmission of pain33,34. We showed that while specific blockers 
for NaV1.7 and NaV1.8 were able to effectively block signal transmission in uninjured cultures, we found that 
they are no longer effective in injured cultures (Fig. 4). The blockers were used at concentrations reported to 
optimally block their target channels with minimal off-target effect. Although, it is possible that at higher con-
centrations these blockers would inhibit synaptic transmission after axotomy, the potential for off-target effects 
limits their utility. Nevertheless, these results clearly demonstrated a significant reduction in the contribution of 
NaV1.8 and NaV1.7 channels to synaptic transmission following axotomy. Interestingly, NaV1.7 and NaV1.8 con-
ditional knock-out in mice does not affect neuropathic pain in SNL model8. Although NaV1.7 loss-of-function 
mutations were known to completely abolish any pain signaling in uninjured patients, one case study reported 
injury-induced neuropathic pain in a patient with NaV1.7 congenital insensitivity to pain35. Hyperactivation of 
the endogenous opioid system has been suggested to underlie insensitivity to pain in patients with NaV1.7 null 
mutations11 and hence lack of efficacy of peripherally acting NaV1.7 blockers in the clinic16. Future experiments 
using more intact preparations, such as spinal cord slices from neuropathic animals, could determine whether 
similar changes in NaV channel contribution to synaptic transmission at the first pain synapse are present in 
neuropathic pain conditions.
Changes in NaV channel expression after injury have been reported in animal models of pain5,7. We explored 
the possibility that the observed switch away from NaV1.7 and NaV1.8 sodium channels in the microfluidic model 
is due to changes in NaV channel expression. We found a modest trend for increase in the expression of NaV1.2, 
NaV1.3, NaV1.6, NaV1.8 and NaV1.9, however, only up-regulation of NaV1.6 mRNA was statistically significant. 
We observed that action potential-evoked calcium transients in DRG axons from axotomized DRG neurons in 
the DH compartment were successfully blocked when NaV1.6-specific blocker were used in combination with 
Nav1.7 and Nav1.8 blockers. The involvement of NaV1.6 is less well studied in neuropathic pain, but recent reports 
suggest a role in certain neuropathic pain models. In humans, a gain-of-function mutation of NaV1.6, which 
lowers its threshold of activation, was recently found in a case of trigeminal neuralgia36. As well, siRNA against 
NaV1.6 reduces mechanical hypersensitivity and allodynia in SNL and modified CCI models of neuropathic 
pain37. Chen et al. have reported that a significant effect of local knock-down of NaV1.6 on mechanical sensitivity 
in neuropathic pain following SNI was observed, while conditional knockout of NaV1.6 in NaV1.8 expressing neu-
rons was partially effective38. Interestingly, no significant upregulation of NaV1.6 protein levels in DRG cell bodies 
was observed37. Our experiments show a clear change in the role of this channel in synaptic transmission after 
axotomy in a microfluidic model of first pain synapse. This dramatic change in the involvement of NaV1.6 could 
be result of trafficking of the channel from the cytosol to the membrane via palmitoylation of δ-catenin shown for 
in vivo injury- and chemotherapy-induced neuropathic pain models or the regulation of NaV1.6 activity through 
upregulation of NaVβ4 auxiliary subunit in inflammatory pain39. Taken together, and assuming positive valida-
tion, the results here would suggest that, in cases of neuropathic pain where NaV1.7 and NaV1.8 blockers admin-
istered in conjunction with blockers of NaV1.6 could be highly effective in reducing pain phenotype.
This would make NaV1.6 an attractive potential therapeutic target for treating respective heritable cases of 
chronic pain and some cases of injury-induced neuropathic pain. As NaV1.6 is also expressed by spinal cord 
neurons38 (Fig. 6), a potential strategy would be local gene therapy37,38,40. Although gene therapy alone may not be 
sufficient for blocking signal transmission, the remaining signaling due to NaV1.7 and NaV1.8 could be blocked 
with existing pharmacological compounds13,41. Nonetheless, any therapeutic strategies should consider potential 
changes in mechanisms of nociceptive signaling following injury to nociceptive neurons.
In summary, this study developed a novel microfluidic based platform which captures the connectivity of 
the peripheral pain pathway. Using this cell culture model, we unmasked a profound shift in Nav channels con-
tributing to synaptic transmission between DRG and DH neurons, from Nav1.7 and Nav1.8 to Nav1.6, following 
severance and recovery of distal axons.
Methods
Materials. All salts and small molecules were purchased from Sigma, unless specified otherwise. Culture 
reagents were purchased from Thermo Fisher Scientific, unless specified otherwise. ProTXII was purchased from 
SmarTox (07PTX002) and used on the day of reconstitution; A803467 (2967) and AHTTX (6159) were purchased 
from Tocris and lidocaine (L5647) and capsaicin were purchased from Sigma.
Cell culture and axotomy. The microfluidic devices (Xona Microfluidics, TCND1000) were assembled 
by non-plasma bonding method42 onto glass bottom dishes (Willco) pre-coated with 0.5 mg/ml poly-L-Lysine 
(P1274, Sigma) in borate buffer. After assembly the surface was coated with 40 µg/ml laminin (L2020, Sigma) in 
Neurobasal medium (Thermo Fisher Scientific).
electrical stimuli (see Methods for details of analysis). Note that, as in Fig. 4, ProTXII and A803467 are effective 
at blocking response in some axons in control cultures (black) in comparison to axotomized cultures (red) 
(*p = 0.039; Welch’s t-test; n = 9 independent experiments). Moreover, combining these blockers with AHTTX 
is highly effective at blocking Ca2+ transients in axons from axotomized cells (***p = 0.00068; Paired t-test, 
n = 9). Scale bars are 100 µm.
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Pregnant Wistar rats (Charles River) were sacrificed and E16 embryos were removed and sacrificed by decap-
itation. All animals were maintained in a designated facility in strict accordance to the UK Home Office Code 
of Practice for the Housing and Care of Animals Used in Scientific Procedures. Animals were sacrificed and 
tissue was collected in strict accordance to the UK Home Office regulations and procedures under Schedule 1 
of Animals (Scientific Procedures) Act 1986. All procedures were approved by the Animal Welfare and Ethical 
Review Body at King’s College London (PPL U136).
The spinal cord was dissected from the embryos and the dorsal root ganglia (DRGs) were collected. The 
dorsal horn segment of the spinal cord was dissected from the lengths of the cord (the meninges were care-
fully removed) and placed in HBSSc (HBSS + 1% Glucose + 20 mM HEPES) +2% BSA and pooled together 
from different embryos. DRGs were digested in 0.125 mg/ml collagenase (C7657, Sigma) and 10 mg/ml dispase 
(17105-041, Thermo Fisher Scientific) in HBSSc for 15–20 minutes, while DH pieces were digested in 30 U/ml 
papain (P4762, Sigma) in Hibernate buffer without Ca2+ (BrainBits UK) for 7–10 minutes. Cells were dissoci-
ated in dissociation buffer containing 0.5 mg/ml DNAse (10104159001, Roche), 1% BSA in NB/B27 (Thermo 
Fisher Scientific), with fire-polished, autoclaved glass Pasteur pipettes and the debris were removed by centri-
fuging DRGs on 15% BSA in HBSSc or DH cells on 5% BSA in NB/B27. After re-suspension of the pellet the 
cells were counted and plated at 10,000 DRGs per µl and 20,000 DH neurons per µl (5 µl total) into respec-
tive compartments as shown in Fig. 1 into the microfluidic devices. Culture medium NB/B27 + GlutaMax (Life 
Technologies) + 50 ng/ml NGF (50385-MNAC, Life Technologies) was added after 1 hour incubation so as to 
minimize cell detachment. At 2 days in vitro (DIV) the medium was replaced completely and supplemented with 
1 µM cytosine β-D-arabinofuranoside (AraC); after that the medium was replaced every 3–4 days. AraC was 
included to slow down the growth of non-neuronal cells in the cultures. Slight positive pressure from DRG soma 
compartment (by adding 40 µl more medium than in the other two compartments) facilitated bilateral spreading 
of the axons from the DRG cells.
Axotomy was performed as described in20 and Tsantoulas, et al.23 with modifications. The axons were cut at 
12–13 DIV by triturating ~200 µl of NB/B27 next to both entrances of the corridor of Periphery compartment 
and washed. Damage of all axons was verified under a microscope and if it was incomplete, the procedure was 
repeated. At the end of the axotomy, both axotomized cells and control cells (medium was changed, but no trit-
uration was applied) had medium replaced with fresh medium and placed back into the incubator for 3 days, at 
which point the cells were probed as described below.
Dye tracing and viral infection. For tracing DRG axons, 1:200 DiO or DiI dyes (Thermo Fisher Scientific) 
dissolved in culture medium were added to the Periphery or DH compartments for 1 hour, washed and allowed 
to diffuse within the cells for at least 1 day before live imaging DRG neurons.
For infecting DRG cells, which have crossed into the Periphery, at 6 DIV the virus with gene encoding for cal-
cium indicator AAV9.CAG.GCaMP6s.WRPE.SV40 (Penn Vector Core, University of Pennsylvania, Philadelphia, 
PA) diluted in medium to ~1.1 × 108 gene copies/µl was added to the corridor under negative pressure and 
washed after 3DIV. Thus, any DRG axons in DH compartment, which expressed GCaMP are bilaterally crossing 
and moreover, where the culture was axotomized at as described above, any green axons would have come from 
injured cells.
Calcium imaging. Cells cultured in microfluidic devices as described above were washed with ACSF 
(130 mM NaCl, 10 mM Na-HEPES, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 30 mM Glucose, pH 7.4; supplemented 
with 1 mM probenecid for imaging Fura-2). For ratiometric calcium imaging, DRG or DH neurons were loaded 
with 2.5 µM Fura-2 dissolved in ACSF for 1 hour in the incubator with occasional rocking and washed before 
imaging.
An inverted fluorescent microscope (Nikon Eclipse TE200) with 20X Plan Fluor, 0.5 NA objective was used for 
all live imaging experiments. For imaging GCaMP, a FITC filter was used and cells were excited at 488 nm wave-
length using a Random Access Monochromator (PTI) with Xenon Short Arc 75 W lamp, while for imaging Fura-2 
at 340 and 380 nm wavelengths, in both cases fluorescence images were acquired by Hamamatsu Orca FLASH 
4.0 at 2 frames per second using EasyRatioPro (PTI) software. To deliver electrical stimuli, a Neurolog NL800A 
stimulus isolators driven by Neurolog signal generators (Digitimer) configured to deliver biphasic stimuli was 
connected to coiled Pt wires submerged into each wells on the side of the corridor in the Periphery compartment. 
It was empirically determined (data not shown) that 5 Hz biphasic pulses (2 ms for each phase) are optimal for 
exciting the majority of the DRG axons and a train of 10 pulses at 2x threshold amplitude (i.e. 40–80 μA) elicit a 
robust response in the DH neurons (concentrations of DMSO up to 0.2% were tested as a control over an imaging 
period of up to 3 hours). The train of pulses was delivered three times for each drug combination with at least 
2.5 minutes in between the trains and at least 10 minutes after each drug application or wash sequence.
Image analysis was done in FIJI. To generate an image of responder cells, an average image of 10 frames 
after the stimulus was divided (or subtracted) by an average of 10 frames before the stimulus to generate ΔR/R0 
(or ΔF) images (macro used for the analysis are deposited at https://github.com/RaoufLab/NV-ImageJ-Scripts), 
where ΔR/R0 is the change in the fluorescence intensity ratio, F340/F380 for Fura-2 experiments (or ΔF/F for 
GCaMP). For ease of visualization “Green Fire Blue” LUT is used throughout the paper with the calibration bar 
next to each image. For DH neurons, cells that responded to electrical stimulation of the periphery compartment 
in the absence of any blockers were selected for further analysis. The mean change in ΔR/R0 for each ROI was 
then calculated for each cell in the presence of the blockers. If the ΔR/R0 was reduced by more than 50%, the cell 
was considered as responding to the blockers. Cells in which the baseline had significantly changed during the 
experiment were discarded. For DRG axons, a threshold mask was applied to the ratioed images of axons during 
electrical stimulus with no blockers, and the same threshold mask was then applied to the images from the same 
field responding to electrical stimulus in the presence of the blockers. The area of responding axons (where all 
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pixels with intensity great than 50 a.u.) was compared and quantified to assess proportion of axons that were 
inhibited by the blockers.
patch clamp electrophysiology. All electrophysiology experiments were performed on an inverted 
Nikon Diaphot-TMD microscope with attached Scientifica CV203BU Headstage. Signal was amplified with 
Axoclamp 200B amplifier and passed through 5 kHz filter, before being digitized with Digidata 1320 A at 10 kHz 
and recorded by pCLAMP 9.2 software (all from Molecular Devices). Series resistance was monitored between 
incubations and recordings were discarded if exceeded 12 MOhm changed significantly or.
For measuring Na+ currents in DRG neurons recording electrodes were made to 2–3 MOhm and filled 
with K+-free solution containing (in mM) 110 CsCl2, 10 HEPES, 10 EGTA, 25 NaOH, 1 MgCl2, 0.1 CaCl2, 2 
ATP-Mg (pH7.4, 250 mOsm). Neurons were perfused with bath solution containing (in mM) 130 NaCl, 3 KCl, 
10 Na-HEPES, 2 CaCl2, 2 MgCl2, 10 Glucose, 5 HCl pH 7.4 (255 mOsm) with drugs as noted in the captions. The 
voltage-clamp protocol involved a negative step to −100 mV and depolarization to −20 mV (for experiments on 
NaV1.7 and NaV1.6 currents) or 0 mV (for experiments on NaV1.8 currents). Difference between peak current at 
0 mV step and baseline current at −100 mV was used for statistical analysis.
For recording post-synaptic currents, the microfluidic devices were modified as described in23 to allow access 
of patch pipettes to DH neurons in the DH compartment. The neurons were patched in pACSF (in mM, 130 
NaCl, 10 Na-HEPES, 2.5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 5.8 HCl pH 7.4, 295 mOsm) and recording elec-
trodes (3–5 MOhm) were filled with physiologically relevant intracellular solution (in mM, 130 K gluconate, 10 
NaCl, 1 MgCl2, 0.2 EGTA, 10 HEPES, 1 ATP-Mg, pH 7.4 with KOH, 270 mOsm). Biphasic electrical stimuli were 
delivered to DRG axons in Periphery compartment with the same equipment and in the same manner as above 
for calcium imaging, voltage measurement was performed for first stimulation, after which the probes were dis-
connected to avoid interference. DH neurons that did not respond to electrical stimuli applied to Periphery were 
discarded, only one incubation with the drugs was performed per device.
Immunocytochemistry. After calcium imaging described above cells were fixed in 4% paraformalde-
hyde in phosphate buffer for 10 minutes, washed and stored at 4 °C. The cells were blocked and permeabilized 
in devices in blocking buffer (5% goat serum, 5% donkey serum + 0.1% Triton-X100) for 1 hour at RT with 
gentle rocking prior to staining. The primary antibodies (or IB4-Alexa 488, Invitrogen, I21411 used at 50 µg/ml): 
chicken anti-GFP (Abcam, ab13970 used 1:1,000), rabbit anti-ATF3 (Novus Biologicals, NBP1-85816 used 
1:200), rabbit anti-NaV1.6 (Alomone, ASC-009 used 1:200), mouse anti-NaV1.7 (Neuromab, N68/6, used 1:500), 
mouse anti-NaV1.8 (Neuromab, N134/12, used 1:200), mouse anti-beta3 tubulin (R&D Systems, MAB1195 used 
1:1,000), goat anti-TRPV1 (Santa Cruz, SC-12498, used 1:500) were incubated with the cells overnight on a rocker 
at 4 °C. Respective secondary antibodies (all from Invitrogen and all used at 1:1,000): goat anti-chicken Alexa 488 
(A11039), donkey anti-mouse Alexa 488 (A21202), donkey anti-mouse Alexa 594 (A21203), donkey anti-rabbit 
Alexa 594 (A21207), donkey anti-goat Alexa 594 (A11058) for 1 hr at RT on a rocker. The cells were imaged 
on Zeiss Imager.Z1 with 20×/0.5NA EC-Plan-NEOFLUAR objective and respective standard DAPI, FITC and 
TRITC filters (to allow imaging on upright microscope the devices were turned upside down) within 2–4 hours 
after washing.
qpcR. DRG and DH neurons were cultured and axotomized as above, washed with PBS and all cells in DRG 
compartment were lysed in 20 µl volume of lysis buffer from RealTime ready Cell Lysis Kit (06366821001, Roche), 
diluted 1:5 and reverse transcribed using Transcriptor Universal cDNA Master (05893151001, Roche). The cDNA 
was used to make 1 ml of Master Mix (using LightCycler 480 Probes Master, 04707494001, Roche) distributed 
among 48 wells of RealTime Ready Custom Panels with optimized primers and probes for a wide range of ion 
channels (05532914001, configuration 100036039, Roche). The cDNA was amplified and product measured using 
LightCycler 480 system (Roche). The data was normalized to geometric mean of four reference genes (Actb, 
Gapdh, S16r and G6pd) and analyzed using conventional 2−ΔCp for relative expression in control or 2−ΔΔCp 
method for measuring fold-change after axotomy43.
Statistical analysis. Paired t-test (Excel) was used to compare the peak response (ΔR/R, ΔF/F or INa) of 
the cells before and after drug applications. Welch’s test (Excel) was used to compare axotomy and control peak 
responses (ΔR/R, ΔF/F), and protein expression using quantification of immunofluorescence.
The changes in relative expression of voltage gated sodium channels were statistically tested by one-sample 
t-test with the p values adjusted to account for multiple comparisons using Bonferroni post-hoc correction.
Data and Code Availability
The raw data, primer and probe sequences as well as live calcium imaging supporting the findings are available 
from the corresponding author, R.R., upon reasonable request. The code used for ICC quantification and process-
ing of calcium imaging data is available from https://github.com/RaoufLab/NV-ImageJ-Scripts, please cite this 
article when using the code.
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